Guided Therapeutics (GTHP) Asset Utilization Ratio (2012 - 2025)

Guided Therapeutics (GTHP) has 14 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 12825.2% year-over-year to 0.69; the trailing twelve-month figure through Dec 2025 stood at 0.69 (up 12825.2% YoY), and the FY2025 full-year result was 0.57, up 12256.19% from the prior year.
• Asset Utilization Ratio climbed to 0.69 in Q4 2025, from 0.19 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q4 2025 to a low of 0.0 in Q1 2025.
• A 5-year average of 0.08 and a median of 0.04 in 2022 frame the typical range for Asset Utilization Ratio.
• Peak annual rise in Asset Utilization Ratio reached 12825.2% in 2025, while the deepest fall reached 98.36% in 2025.
• Tracing GTHP's Asset Utilization Ratio over 5 years: stood at 0.04 in 2021, then slumped by 91.61% to 0.0 in 2022, then jumped by 1438.52% to 0.06 in 2023, then slumped by 90.36% to 0.01 in 2024, then soared by 12825.2% to 0.69 in 2025.
• Business Quant data shows GTHP's Asset Utilization Ratio at 0.69 in Q4 2025, 0.19 in Q3 2025, and 0.12 in Q2 2025.